Researchers identify CDC20, DTL, & RRM2 as #AR‑independent drivers of advanced #ProstateCancer via RB1/E2F1, with novel inhibitors surpassing AR antagonists, offering new #CastrationResistant targets & a #bioinformatics‑driven discovery paradigm.
#OpenAccess: doi.org/10.1016/j.ge...